Pylephlebitis: A Rare but Redoubtable Complication of Intra-Abdominal Infections-A Series of 15 Cases

Serban Nicolae Benea1,2, Teodora Deaconu1,2, Dragos Florea1,2

  • 1Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Life (Basel, Switzerland)
|October 29, 2025
PubMed

Insights

Pylephlebitis, a rare portal vein infection, is effectively managed in infectious disease settings. Prompt antibiotic and anticoagulant treatment improves outcomes for this serious intra-abdominal infection.

Area of Science:

  • Infectious Diseases
  • Internal Medicine
  • Radiology

Background:

  • Pylephlebitis, defined as suppurative thrombosis of the portal vein system, is an infrequent yet severe intra-abdominal infection.
  • Historically associated with complications from diverticulitis or appendicitis, it is predominantly reported in surgical literature.

Purpose of the Study:

  • To evaluate the efficacy and role of managing pylephlebitis within an infectious disease clinical setting.
  • To analyze the clinical characteristics, radiological findings, and treatment outcomes of pylephlebitis patients managed by infectious disease specialists.

Main Methods:

  • Retrospective review of medical records from 2001 to 2024 at a tertiary infectious diseases hospital.
  • Inclusion criteria focused on patients diagnosed with pylephlebitis, with data extraction on demographics, clinical presentation, radiological findings, microbiological data, and treatment regimens.
  • Analysis of treatment outcomes, including mortality and need for surgical intervention.

Main Results:

  • Fifteen cases of pylephlebitis were identified, with a median age of 58 years and a male predominance (4:1 ratio).
  • Portal vein thrombosis (PVT) accompanied by liver abscesses was the predominant radiological finding (80% of cases).
  • Gram-negative aerobic bacteria were the most common isolates (5/8 positive blood cultures), with polymicrobial infections occurring in half of cases. Prompt broad-spectrum antibiotic therapy and anticoagulation were administered to most patients.

Conclusions:

  • An infectious disease setting is crucial for the effective management of pylephlebitis.
  • Early diagnosis and aggressive treatment with broad-spectrum antibiotics and anticoagulation are vital for improving patient outcomes.
  • Liver abscesses are common sequelae, emphasizing the need for comprehensive management strategies.

Related Concept Videos

Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
469
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
305
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
559
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
528
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
513
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
743